3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hematopoietic and Lymphatic System Neoplasm
8
Breast Neoplasms
8
Lung Neoplasms
5
Prostatic Neoplasms
4
Malignant Solid Neoplasm
4
Colorectal Neoplasms
4
Ovarian Neoplasms
3
Hematologic Neoplasms
3
Thyroid Cancer, Papillary
2
Oropharyngeal Neoplasms
2
Neoplasms
2
Multiple Myeloma
2
Mouth Neoplasms
2
Melanoma
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Head and Neck Neoplasms
2
Depression
2
Colonic Neoplasms
2
Carcinoma
2
Anatomic Stage I Breast Cancer AJCC v8
2
Advanced Malignant Solid Neoplasm
2
Adenocarcinoma, Follicular
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spondylitis, Ankylosing
1
Smoking Cessation
1
Sarcoma
1
Interventions
pembrolizumab
22
Nivolumab
14
enfortumab vedotin
13
Gemcitabine
11
Specimen Handling
9
Magnetic Resonance Spectroscopy
9
Cisplatin
8
Carboplatin
8
sacituzumab govitecan
6
avelumab
6
Docetaxel
6
atezolizumab
5
Ipilimumab
5
durvalumab
4
Paclitaxel
4
cabozantinib
3
Taxes
3
Mitomycin
3
CTLA-4 Antigen
3
tislelizumab
2
relatlimab
2
erdafitinib
2
disitamab vedotin
2
Radiosurgery
2
Platinum
2
Oxaliplatin
2
Immunoglobulin G
2
Fluorouracil
2
Disulfides
2
ALT-803
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
Interviews as Topic
×
90 days
×
Clear all
No trials found.